| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Director | Sep 11, 2024 | Option Exercise | $3.67 | 11,016 | 40,429 | 21,018 | Sep 11, 2024, 07:00 PM | |
| AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Director | Sep 11, 2024 | Sale | $91.31 | 11,016 | 1,005,871 | 10,002 | Sep 11, 2024, 07:00 PM | |
| AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Director | Nov 17, 2021 | Buy | $34.53 | 3,000 | 103,597 | 10,002 | Nov 19, 2021, 07:30 AM | |
| AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Director | Nov 17, 2021 | Buy | $34.42 | 300 | 10,325 | 100 | Nov 19, 2021, 07:30 AM | |
| AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Director | May 23, 2019 | Buy | $22.33 | 3,500 | 78,155 | 7,002 | May 24, 2019, 07:19 AM | |
| AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Director | Nov 24, 2015 | Option Exercise | $5.94 | 3,502 | 20,802 | 3,502 | Nov 24, 2015, 04:24 PM | |
| CYTX | CYTORI THERAPEUTICS, INC. | Saad Mark E | Chief Financial Officer | Mar 14, 2012 | Buy | $2.55 | 10,000 | 25,494 | 152,500 | Mar 14, 2012, 06:32 PM | |
| CYTX | CYTORI THERAPEUTICS, INC. | Saad Mark E | Chief Financial Officer | Aug 12, 2011 | Buy | $3.12 | 6,500 | 20,290 | 122,500 | Aug 12, 2011, 02:34 PM |
Menu